Who Should Report an Error?

Mix-Ups Between Five Different Inhalers that All Include “Ellipta” as Part of Their Brand Names

The name of a unique inhaler device included in five different brand name medicines has led to multiple mix-ups, not only by consumers but by doctors, pharmacists, and nurses as well. In 2013, the global drug company, GlaxoSmithKline, introduced Ellipta, a new type of inhaler device. It is circular in shape, about the size of a hockey puck, and can combine several different medicines together. The company has packaged combinations of one, two, or three of the medicines listed below using this unique inhaler device:

“My Medicines List” Available in English and Spanish

Before Leaving the Doctor’s Office, Expect Medication Information

It was double trouble for a patient when she and her doctor both made errors and it led to a 4-fold overdose of an antidepressant medication, CELEXA (citalopram Hydrobromide). The patient was starting this medication for the first time and after three days she began to experience severe anxiety, agitation, nausea, and severe fatigue. She called her doctor about her symptoms. The error was identified when they reviewed the medication together and realized what was causing the problem – a medication error.

Hazard: Unmet Technology Support Needs for Patients Being Cared for at Home